iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Sep 15, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -33.04 | -18.38 | -24.91 | -65.01 | -50.3 |
Depreciation & Amortization | 1.03 | 1.13 | 1.25 | 1.09 | 0.92 |
Other Amortization | - | - | 0.12 | 0.24 | 0.11 |
Loss (Gain) From Sale of Assets | - | - | 3.91 | -0.78 | - |
Asset Writedown & Restructuring Costs | 5.11 | - | 3.1 | 18.47 | - |
Loss (Gain) From Sale of Investments | -0.19 | - | - | 0.17 | 2.07 |
Stock-Based Compensation | 1.37 | 1.53 | 2.04 | 4.39 | 4.38 |
Provision & Write-off of Bad Debts | 0.07 | - | - | - | - |
Other Operating Activities | -0.08 | -0.06 | -0.9 | 4.84 | -0.77 |
Change in Accounts Receivable | -0.07 | - | - | 1 | -0.89 |
Change in Inventory | - | - | - | -1.02 | -3.87 |
Change in Accounts Payable | 2.22 | 1.83 | -1.49 | -0.63 | 1.24 |
Change in Unearned Revenue | -0.05 | 0.25 | 0.2 | -0.1 | 0.01 |
Change in Other Net Operating Assets | 0.41 | -1.6 | -1.88 | 6.61 | 6.76 |
Operating Cash Flow | -23.22 | -15.3 | -18.55 | -30.44 | -37.48 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.58 | -0.02 | -0.21 | -6.43 | -7.33 |
Sale of Property, Plant & Equipment | - | - | 0.12 | 2.6 | - |
Sale (Purchase) of Intangibles | - | - | 1 | - | -4.3 |
Investment in Securities | -31.5 | - | - | 10.84 | 6.5 |
Other Investing Activities | 0.08 | 0.76 | - | - | - |
Investing Cash Flow | -32 | 0.74 | 0.91 | 7.01 | -5.13 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | - | - | 0.9 | 0.5 | - |
Short-Term Debt Repaid | - | - | -1.51 | -9.32 | - |
Long-Term Debt Repaid | -0.77 | -0.7 | -0.52 | -0.31 | -5.83 |
Total Debt Repaid | -0.77 | -0.7 | -2.03 | -9.63 | -5.83 |
Net Debt Issued (Repaid) | -0.77 | -0.7 | -1.14 | -9.13 | -5.83 |
Issuance of Common Stock | 37 | 3.67 | 25.73 | 11.49 | 0.08 |
Repurchase of Common Stock | - | - | -0.01 | -0.04 | - |
Other Financing Activities | 66.82 | 5.95 | -0.09 | -0.02 | -0.37 |
Financing Cash Flow | 103.05 | 8.93 | 24.49 | 2.3 | -6.13 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | - | - | - | 0.03 | - |
Net Cash Flow | 47.83 | -5.63 | 6.85 | -21.09 | -48.73 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -23.8 | -15.32 | -18.76 | -36.87 | -44.81 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -23796.00% | -3830.00% | -8339.56% | - | -2378.45% |
Free Cash Flow Per Share | -0.23 | -1.46 | -4.90 | -60.24 | -102.76 |
Levered Free Cash Flow | -13.62 | -6.65 | 8.36 | -30.52 | -26.63 |
Unlevered Free Cash Flow | -13.59 | -6.52 | 8.35 | -30.71 | -26.74 |